Furthermore, recent studies have shown that the proliferative capacities of CD8 T-cells during chronic hepatitis are affected by increased regulatory T-cell (Tregs) levels [38], [39] and by an imbalance between Tregs and T helper cells that produce interleukin-17 (Th17) [40]. The gene discussed is IL17A; the disease is chronic hepatitis.